Literature DB >> 20583342

Cancer: Second-line therapy for adrenocortical carcinoma proves beneficial.

Vicky Heath.   

Abstract

Entities:  

Year:  2010        PMID: 20583342     DOI: 10.1038/nrendo.2010.76

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study.

Authors:  Paola Sperone; Anna Ferrero; Fulvia Daffara; Adriano Priola; Barbara Zaggia; Marco Volante; Daniele Santini; Bruno Vincenzi; Giuseppe Badalamenti; Chiara Intrivici; Sabrina Del Buono; Silvia De Francia; Emmanouil Kalomirakis; Riccardo Ratti; Alberto Angeli; Luigi Dogliotti; Mauro Papotti; Massimo Terzolo; Alfredo Berruti
Journal:  Endocr Relat Cancer       Date:  2010-04-21       Impact factor: 5.678

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.